Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress. Bartlett NL. J Clin Oncol 2021 Aug 24:JCO2101552. doi: 10.1200/JCO.21.01552.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartlett NL. Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress. J Clin Oncol 2021 Aug 24:JCO2101552. doi: 10.1200/JCO.21.01552.
PMID: 34428096